Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Wake Forest University Abbott |
---|---|
Information provided by: | Wake Forest University |
ClinicalTrials.gov Identifier: | NCT00205634 |
The purpose of this study is to evaluate whether Biaxin (clarithromycin) improves sputum abnormalities, lung function, and overall feeling of well-being in people with cystic fibrosis (CF). Biaxin is an antibiotic commonly used for the treatment of respiratory infections in people who do not have CF, and is sometimes used in CF patients as well. Studies done in a disease called diffuse panbronchiolitis (which is similar to CF) and some preliminary studies that have been done in CF patients suggest that Biaxin might have a beneficial effect on CF sputum in ways unrelated to its antibiotic activity.
Condition | Intervention |
---|---|
Cystic Fibrosis |
Drug: Biaxin ( clarithromycin) |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study |
Official Title: | Macrolide Antibiotic Therapy for Patients With Cystic Fibrosis |
Estimated Enrollment: | 50 |
Study Start Date: | December 2000 |
Estimated Study Completion Date: | October 2004 |
Ages Eligible for Study: | 6 Years to 50 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, North Carolina | |
Wake Forest University Health Sciences | |
Winston-Salem, North Carolina, United States, 27157 |
Principal Investigator: | Bruce K Rubin, MEngr,MD,MBA | Wake Forest University |
Study ID Numbers: | BG99-486 |
Study First Received: | September 12, 2005 |
Last Updated: | December 13, 2007 |
ClinicalTrials.gov Identifier: | NCT00205634 |
Health Authority: | United States: Institutional Review Board |
Cystic Fibrosis (CF) Macrolide antiobiotics airway inflammation |
Clarithromycin Digestive System Diseases Genetic Diseases, Inborn Respiratory Tract Diseases Cystic Fibrosis Fibrosis |
Lung Diseases Infant, Newborn, Diseases Pancreatic Diseases Cystic fibrosis Inflammation |
Anti-Infective Agents Anti-Bacterial Agents Protein Synthesis Inhibitors Pathologic Processes |
Molecular Mechanisms of Pharmacological Action Therapeutic Uses Enzyme Inhibitors Pharmacologic Actions |